Hanger, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 16 rows in 2022. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-10-03: Reporting owner ASAR VINIT K; Form 4; Security Stock Options (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2022-10-03: Reporting owner Campbell James H; Form 4; Security Stock Options (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2022-10-03: Reporting owner Kiraly Thomas E; Form 4; Security Stock Options (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2022-03-16: Reporting owner Kiraly Thomas E; Form 4; Security Stock Options (right to buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-10-03 | ASAR VINIT K Director, Officer (President and CEO) | 4 | Stock Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −159,982 0 owned after | $5.98 | 2022-10-04 | |
| 2022-10-03 | Campbell James H Officer (SVP, Chief Clinical Officer) | 4 | Stock Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −27,328 0 owned after | $5.98 | 2022-10-04 | |
| 2022-10-03 | Kiraly Thomas E Officer (EVP & Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −31,389 0 owned after | $5.98 | 2022-10-04 | |
| 2022-03-16 holding as of filing | Kiraly Thomas E Officer (EVP & Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 31,389 owned after | $12.77 exercise price | 2022-03-16 | |
| 2022-03-11 holding as of filing | Kiraly Thomas E Officer (EVP & Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 31,389 owned after | $12.77 exercise price | 2022-03-11 | |
| 2022-03-11 holding as of filing | Campbell James H Officer (SVP, Chief Clinical Officer) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 27,328 owned after | $12.77 exercise price | 2022-03-11 | |
| 2022-03-11 holding as of filing | ASAR VINIT K Director, Officer (President and CEO) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 159,982 owned after | $12.77 exercise price | 2022-03-11 | |
| 2022-03-10 holding as of filing | Kiraly Thomas E Officer (EVP & Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 31,389 owned after | $12.77 exercise price | 2022-03-10 | |
| 2022-03-10 holding as of filing | Campbell James H Officer (SVP, Chief Clinical Officer) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 27,328 owned after | $12.77 exercise price | 2022-03-10 | |
| 2022-03-10 holding as of filing | ASAR VINIT K Director, Officer (President and CEO) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 159,982 owned after | $12.77 exercise price | 2022-03-10 | |
| 2022-03-08 holding as of filing | Campbell James H Officer (SVP, Chief Clinical Officer) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 27,328 owned after | $12.77 exercise price | 2022-03-08 | |
| 2022-03-08 holding as of filing | Kiraly Thomas E Officer (EVP & Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 31,389 owned after | $12.77 exercise price | 2022-03-08 | |
| 2022-03-08 holding as of filing | ASAR VINIT K Director, Officer (President and CEO) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 159,982 owned after | $12.77 exercise price | 2022-03-08 | |
| 2022-02-16 holding as of filing | Campbell James H Officer (SVP, Chief Clinical Officer) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 27,328 owned after | $12.77 exercise price | 2022-02-16 | |
| 2022-02-16 holding as of filing | Kiraly Thomas E Officer (EVP & Chief Financial Officer) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 31,389 owned after | $12.77 exercise price | 2022-02-16 | |
| 2022-02-16 holding as of filing | ASAR VINIT K Director, Officer (President and CEO) | 4 | Stock Options (right to buy) Derivative · Direct | Holding | 159,982 owned after | $12.77 exercise price | 2022-02-16 |